Picture Fairtec GmbH Worldwide Event Solutions 650x65px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5496 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 47 48 49 ... 53 54 55  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Anergis–SEVERAL: investment, 201103 financing round Series A CHF18m led by Vinci Capital + BioMedInest + Sunstone Capital 2011-03-28
Moldiax–Analytik Jena: investment, 201103 acquisition 23.5% share by Analytik Jena AG 2011-03-24
Nimbus Discovery–Proteros: drug discovery services, 201103– supply service delivery of X-ray protein crystal structures for multiple targets 2011-03-23
AMSilk–SEVERAL: investment, 201103 financing round Series B €5m incl investors MIG Fonds + AT Newtec 2011-03-17
Seegene–Kompass: MolYsis technology, 201103– collab Seegene Magicplex Sepsis test is based on Molzym MolYsis and Nordiag's Arrow system 2011-03-17
MorphoSys–Boehringer: biopharmaceutical contract manufacturing, 201103– supply service process develop + manufacturing for MOR208 program 2011-03-16
Instraction–Protagen: protein separation, 201103– collab developm customised instAction Phases for downstream processing of biotherapeutics 2011-03-15
PVT Probenverteiltechnik–Roche: investment, 201103 acquisition €65m upfront + up to €20m milestones 2011-03-15
Takeda–Evotec: mass spectrometry services, 201103– collab Kinaxo will apply PhosphoScout techn to assist drug developm research of Takeda 2011-03-15
GNA Biosolutions–PERSON: investment, 201103 1st financing round €na capital increase by private investor from Munich 2011-03-14
NovaShunt–SEVERAL: investment, 201103 financing round Series B CHF23.7m=$25m 2011-03-09
Avacta–V&F: mass spectrometer, 201103 distribution of IMR-MS systems + services in UK + IRL by Oxford Molecular Diagnostics 2011-03-07
Biomat-IN project–BioRegio STERN: biomaterials, 201103–201402 collab BioRegio STERN is project partner 2011-03-01
Biomat-IN project–EU (govt): grant, 201103–201402 support €1.24m from ERDF under Interreg IVB North West Europe 2011-03-01
BioRegio STERN–EU (govt): grant, 201103–201402 ERDF support €1223k as partner in Biomat-IN EU project 2011-03-01
Life Sciences Bremen–Bionsys: life sciences, 201103– membership Bionsys joins LSB 2011-03-01
Theragenics–Eckert & Ziegler: investment, 201103–201104 unfriendly takeover offer $2.2/share NOT REALISED 2011-03-01
Qiagen–Epigenomics: DNA methylation analysis, 201102– license option ww non-excl to SEPT9 biomarker + DNA methylation technologies (LT) 2011-02-28
Applikon–Automation Partnership: laboratory equipment, 201102– distribution of ambr™ + Fill-It™ in Benelux by Applikon 2011-02-24
Michrom–Bruker: investment, 201102–201104 acquisition €na 2011-02-24
NEU² project–Biotest: MS drug RnD, 201102– collab Biotest AG becomes project member for clinical developm of BT-061 in MS 2011-02-24
Biofrontera–SEVERAL: investment, 201102 private placement capital increase €1.8m 880k new shares 2011-02-22
Euroimmun–Scienion: print/spotting technology, 201102 supply sciFLEXARRAYER for r+d + production purposes of microarray diagnostic products 2011-02-21
Max Planck–Proteros: drug discovery services, 201102– supply preferred service partner to support kinase drug discovery research 2011-02-21
Süd-Chemie–Clariant: investment, 201102–201111 acquisition €2b in cash + shares 2011-02-16
Evotec–ChemBridge: chemical compound libraries, 201102– supply €na access to initially 110k compounds from ChemBridge Library Collection 2011-02-15
Chemagen–PerkinElmer: investment, 201102 acquisition 2011-02-14
Kinaxo–Evotec: investment, 201102–201104 acquisition €12m upfront with €3m in cash + 2.6m shares plus up to €4m cash milestones 2011-02-09
Danaher–GeneBio: bioinformatics, 201102– collab co-marketing SmileMS with AB Sciex mass spectrometers 2011-02-08
Beckman Coulter–Danaher: investment, 201102–201106 acquisition cash tender offer $6.8b $83.5/share 2011-02-07
Activaero–SEVERAL: investment, 201102 financing round €5m led by LSP Life Sciences Partners with €3.5m 2011-02-02
Scil–Coral BioNet: investment, 201102 financing round €24m for Scil Proteins from own majority holder BioNet Holding 2011-02-02
SuperGen–Proteros: drug discovery services, 201102– supply service use integrated lead discovery platform to discover small-molecule lead compounds 2011-02-02
Genzyme–Sekisui: investment, 201102 acquisition of Genzyme Virotech GmbH by Sekisui Chemial 2011-02-01
PharmaSwiss–Valeant: investment, 201102–201103 acquisition €350m + €30m milestones 2011-02-01
SAW Instruments–Germany (govt): investment, 201102 2nd financing round totalling €1m incl new investor KfW 2011-02-01
SAW Instruments–High-Tech Gründerfonds: investment, 201102 2nd financing round totalling €1m incl returning investor High-Tech Gründerfonds 2011-02-01
SAW Instruments–KI Kapital: investment, 201102 2nd financing round totalling €1m incl returning investor KI Kapital GmbH 2011-02-01
SAW Instruments–SEVERAL: investment, 201102 2nd financing round €1m KI Kapital + HTGF + KfW 2011-02-01
Resource Technology Corp–Sigma-Aldrich: investment, 201101 acquisition of assets of RTC €na by Sigma-Aldrich 2011-01-31
Bayer–Zydus Cadila: pharmaceuticals, 201101– collab 50/50 joint venture Bayer Zydus Pharma established to develop Indian market 2011-01-28
FCB-Pharmicell–RNL Bio: investment, 201101 acquisition 99.5% of Pharmicell Europe GmbH to be renamed RNL Europe GmbH 2011-01-25
Genoptix–Novartis: investment, 201101– cash tender offer $470m $25/share 2011-01-24
Genoptix–Novartis: investment, 201701–201703 DIVESTMENT sale €na of Genoptix (excl biopharma business) to Ampersand + 1315 Capital + new managers 2011-01-24
Takeda–Evotec: drug discovery services, 201101– supply service €na identification small molecules against CNS + metabolic targets for Takeda Cambridge 2011-01-20
Merck (DE)–Domain Therapeutics: mGLuR4 PAM, 201101– collab excl developm + licensing €2m upfront + €132m milestones + royalties for Parkinson 2011-01-17
Mologen–Salvator Vermögensverwaltungs GmbH: investment, 201101 existent long-time investor 2011-01-14
Univ Bonn–Danaher: mass spectrometer, 201101 supply existent ABI STR Voyager at IBMB 2011-01-14
Univ Bonn–Thermo Fisher: mass spectrometer, 201101 supply existent LTQ Orbitrap Velos at IBMB 2011-01-14
4-Antibody–Advent Venture Partners: investment, 201101 existent listed as current portfolio company of Advent 2011-01-13
Caterna–High-Tech Gründerfonds: investment, 201101 financing round totalling €650k incl investor High-Tech Gründerfonds 2011-01-13
Caterna–Saxony (govt): investment, 201101 financing round totalling €650k incl investor Technologiegründerfonds Sachsen 2011-01-13
Caterna–SEVERAL: investment, 201101 financing round €650k from Technologiegründerfonds Sachsen + High-Tech Gründerfonds 2011-01-13
Laboratoires Expanscience–Medigene: Veregen, 201001– license + supply for excl commercialisation + marketing in France 2011-01-13
Medigene–Advent Venture Partners: investment, 201101 existent listed as current portfolio company of Advent 2011-01-13
Micromet–Advent Venture Partners: investment, 201101 existent listed as current portfolio company of Advent 2011-01-13
Mologen–Berliner Effektengesellschaft: financial services, 201101 service Quirin Bank subscription agent for capital increase up to 1.246m new shares 2011-01-13
Mologen–Kirchhoff Consult: public relations, 201101 service existent investor relations 2011-01-13
Mologen–SEVERAL: investment, 201101–201102 capital increase €10m 1.246m new shares €8/share 2011-01-13
DiaSorin–Tecan: lab automation, 201101– supply €na OEM automated ELISA system based on Freedom EVOlyzer platform incl detetcion instruments 2011-01-12
EyeSense–Qiagen: investment, 201101 acquisition minority equity stake €na by Qiagen in connection with strategic partnership 2011-01-12
Qiagen–EyeSense: blood glucose measuring device, 201101– collab development combining EyeSene techn with ESE fluorescence-based optical techn 2011-01-12
Vaximm–SEVERAL: investment, 201101 financing round private CHF7.8m 2011-01-12
Alacris–Max Planck: ModCell™ system, 201101 license excl existent from MPI for Molecular Genetics 2011-01-11
Alacris–Qiagen: investment, 201101 acquisition €na minority stake 2011-01-11
Alcon–MerLion: finafloxacin, 201101– license excl developm + commercialisation in North America for ear infections w option to expand license 2011-01-11
Bayer–Univ California: pharma research, 201101– master agreement for research collaborations of Bayer HealthCare with UCSF 2011-01-11
Lilly–Boehringer: antidiabetic drugs, 201101– collab strategic alliance ww joint developm + marketing of portfolio of diabetes drugs 2011-01-11
LZS-Concept–Analytik Jena: laboratory equipment, 201101– distribution and service in Austria by LZS-Concept Handels- und Service GmbH 2011-01-11
Qiagen–Alacris: biomarker, 201101– excl option €na to access all biomarkers for individualised cancer treatment 2011-01-11
Roche–Expression Pathology: Liquid Tissue-SRM technology, 201101– supply protein biomarker assay services to support Roche oncology drug development 2011-01-11
Tecan–Enigma Diagnostics: molecular diagnostics, 201101– license + collab €na use of Enigma ML for OEM diagnostic platforms by Tecan 2011-01-11
AJ Innuscreen–Analytik Jena: investment, 201101 investment increase of ownership to 100% 2011-01-10
Apeiron–PR&D: public relations, 201101 service strategic communication consulting + national + international media service 2011-01-10
Comicom–Analytik Jena: investment, 201101 acquisition 55% by AJ Blomesystem GmbH 2011-01-10
Gilupi–Aurelia Private Equity: investment, 201101 3rd financing round totalling €3.6m incl investor Aurelia Private Equity 2011-01-10
Gilupi–Brandenburg (govt): investment, 201101 3rd financing round totalling €3.6m incl investor Brandenburg Capital BFBII 2011-01-10
Gilupi–Germany (govt): investment, 201101 3rd financing round totalling €3.6m incl investor KfW Bankengruppe 2011-01-10
Gilupi–High-Tech Gründerfonds: investment, 201101 3rd financing round totalling €3.6m incl investor HTGF 2011-01-10
Gilupi–SEVERAL: investment, 201101 3rd financing round €3.6m Aurelia Private Equity + Brandenburg Capital + KfW+ High-Tech Gründerfonds 2011-01-10
JnJ–Biocartis: molecular diagnostics, 201101– strategic collab €na ww excl co-developm + marketing assays for neurological disease + some infections 2011-01-10
Synosia–Biotie: investment, 201101–201102 merger acquisition €93.6m 2011-01-10
Takeda–Pieris: Anticalin scaffold technology, 201101– collab €na drug discovery Anticalin therapeutic protein candidates Takeda San Francisco 2011-01-10
Teva–Lonza: biogenerics, –201101–201307 collab joint venture TERMINATED 7/13 2011-01-10
AstraZeneca–Kinaxo: mass spectrometry services, 201101– supply service €na Kinaxo to apply its technology to support one AZ oncology program 2011-01-05
Lonza–IDBS: data management software, 201101– supply Bioprocess Execution System software for mammalian cell culture process development 2011-01-05
sense2care–High-Tech Gründerfonds: investment, 201101 HTGF invests €500k 2011-01-04
Centogene–PERSON: investment, 201101 equity investment Martin Schlenk becomes major shareholder + CEO of Centogene Holding AG 2011-01-01
Dr. Falk Pharma–Zedira: transglutaminase inhibitor, 2011– license to ZED1227 in Europe plus joint ownership of rights outside Europe 2011-01-01
iThera Medical–Germany (govt): grant, 2011 GO-Bio phase 2 grant from BMBF 2011-01-01
JnJ–Molecular Partners: DARPins, 2011–201610 collab + license DARPin targeting IL-13 + IL-17 against pulmonary disease TERMINATED 10/16 2011-01-01
Meiji Seika Kaisha–Newron: safinamide, 2011– license to develop + manufacture + commercialise safinamide in Asia to Meiji Seika Pharma 2011-01-01
MicroAQUA project–EU (govt): grant, 2011– FP7 grant to develop DNA microarray for water analysis 2011-01-01
MicroAQUA project–Scienion: DNA microarrays, 2011– collab Scienion is project member + final marketer of resulting DNA microarray for water analysis 2011-01-01
Pfizer–Kohlberg Kravis Roberts: investment, 2011 acquisition of Capsugel from Pfizer by KKR 2011-01-01
Rebiotix–SEVERAL: investment, 2011 seed financing round $5m 2011-01-01
Select Biosciences–Alto Marketing: public relations, 2011– service public relations for European Lab Automation in Hamburg 2011 + 2012 2011-01-01
Springer–ASMS: Journal of the American Society for Mass Spectrometry, 2011– collab Springer to publish ASMS Journal before Elsevier 2011-01-01
Univ Cambridge–Agilent: mass spectrometer, 2011 supply Agilent 6460 Triple Quad MS with 1290 Infinity LC to Ralser Lab 2011-01-01
Vita Diagnostika–Euro Diagnostica: investment, 2011 acquisition 2011-01-01
next pagenext page 1 2 3 ... 47 48 49 ... 53 54 55  next pagenext page


Picture [LSUS] – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture [LSA] – The Business Web Portal 650x89px

» top